George J. Kaptain, M.D.

George kaptain

George J. Kaptain, MD is the Director of Neuro-Oncology, Skull-Base Surgery and Radiosurgery within the Department of Neurosurgery at Hackensack University Medical Center. He is also the Surgical Director of the Neuro-Oncology program at the Brain and Spine Institute of the John Theurer Cancer Center and is a lead investigator in several active clinical trials for brain tumors.

Dr. Kaptain specializes in the surgical and radiosurgical treatment of benign and malignant tumors of the brain, spine and skull-base. He has advanced the quality of care in the region by assembling a multi-disciplinary team of surgeons to develop an endoscopic skull-base program, as well as, utilizing motor mapping and neurophysiological monitoring for the resection of brain tumors of the eloquent cortex.

Dr. Kaptain is a board certified neurosurgeon with over ten years experience. He received both his medical degree and neurosurgical training from the University of Virginia in Charlottesville, Virginia followed by sub-specialty training in neuro-oncology and skull-base surgery at the Oregon Health Sciences University in Portland, Oregon. He has published articles in peer-reviewed journals including the Journal of Neurosurgery and Neurosurgery, and has presented this work at the American Association of Neurosurgeons and the Congress of Neurosurgeons. He is actively engaged in teaching physicians in training from the University of Medicine and Dentistry of New Jersey and the St. Barnabas Medical System.

Dr. Kaptain has been recognized as a neurosurgeon of note by New Jersey Monthly and named a "Top Surgeon" by the Consumer's Research Council of America. His dedication to patient care is evidenced by his consistent record of outstanding ratings by both patients and fellow physicians alike.


Dr. Kaptain and the John Theurer Cancer Center's segment in this video begins at the 19:25 mark.
Brain Tumors: Caution is Key
Community rallies behind Cedar Grove's Bill Fearon, who was diagnosed with cancerous brain tumor
HUMC Foundation Receives $100,000 Donation to Benefit the Caroline Vandemark Fund for Brain and Spine Tumor Research